Test

Broad Coverage Bartonella Ab Assay

$195.00

The Bartonella Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to Bartonella antigens in human serum. A positive test suggests exposure to Bartonella, and should be used in conjunction with patient clinical symptoms and history. The BCA Assay is a simple and cost-effective test, which gives either a positive or negative result.

Principle
Detects IgM and IgG antibodies to Bartonella, and a positive test suggests exposure to Babesia , and should be used in conjunction with patient clinical symptoms and history. For specific protein or band information, an ImmunoBlot IgM or IgG test should be ordered to provide more information and possible speciation of the Bartonella. The sensitivity of the Bartonella BCA Assay is greater than 90%, and the specificity is greater than 94%.

Tube / Specimen Requirements
1 SST/ minimum volume 0.5mL serum

CPT Code(s)
86611

Test Number 611 Categories , Tags , Stage of Disease

Any Stage of Disease

Test Methodology

ImmunoBlot

Available in New York

No

• Far broader and more inclusive of Bartonella species than standard serologies.
• Detects antibodies to Bartonella from around the world
• Provides a simple, cost-effective, yes/no result with no complicated interpretation necessary

Positive: Bartonella antigens detected.
Negative: Bartonella antigens not detected

A positive result suggests exposure to Bartonella. For diagnostic purposes, test results should be used in conjunction with clinical symptoms and other evidence available to the diagnosing physician. If the test result is indeterminate, testing with another method or retesting in 6-8 weeks is recommended.

GET STARTED TODAY!

The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.

WHY IGENEX FOR TICK-BORNE DISEASE TESTING?

igenex-laboratory-milpitas